PCMC
GNMX

Private Capital Management (Colorado)’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Private Capital Management (Colorado)’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,306
Closed – – 106
2020
Q1 		$0 Buy
+15,306
New +$2.92K ﹤0.01% 111

Private Capital Management (Colorado)'s GNMX Position: Q2 2020 in Review

Private Capital Management (Colorado) sold out of Aevi Genomic Medicine Inc (GNMX) in Q2 2020, closing a stake of 15,306 shares.

Private Capital Management (Colorado) first reported a position in GNMX in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 0 funds tracked by Wall St. Rank hold GNMX as of Q2 2020.

  • Private Capital Management (Colorado) reported no remaining Aevi Genomic Medicine Inc position as of Q2 2020 after selling out during the quarter.
  • Private Capital Management (Colorado) sold 15,306 Aevi Genomic Medicine Inc shares in Q2 2020.
  • Private Capital Management (Colorado) first reported a position in Aevi Genomic Medicine Inc in Q1 2020 and held it in 1 quarter.
  • Private Capital Management (Colorado)'s Aevi Genomic Medicine Inc position peaked at $0 in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q2 2020.

Based on Private Capital Management (Colorado)'s 13F filing for Q2 2020, filed 8 Jul 2020.